Page last updated: 2024-08-23

bromocriptine and docetaxel anhydrous

bromocriptine has been researched along with docetaxel anhydrous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, Y; Du, Y; Fu, H; Kavuri, S; Kucuk, O; Li, X; Mamouni, K; Wu, D; Yang, Y1

Reviews

1 review(s) available for bromocriptine and docetaxel anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for bromocriptine and docetaxel anhydrous

ArticleYear
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.
    Molecular cancer therapeutics, 2018, Volume: 17, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bromocriptine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Docetaxel; Dopamine Agonists; Drug Repositioning; Drug Synergism; Humans; Male; Mice, Nude; Prostatic Neoplasms; Receptors, Dopamine D2; Xenograft Model Antitumor Assays

2018